The global artificial intelligence (AI) in drug repurposing market was valued at USD 1.3 billion in 2025 and is estimated to reach USD 1.7 billion in 2026. The market is projected to expand to USD 7.7 billion by 2033, registering a 24.5% CAGR from 2026 to 2033. North America accounted for the largest revenue share at 52.9% in 2025, supported by a strong...